Ignite Creation Date:
2024-05-05 @ 5:36 PM
Last Modification Date:
2024-10-26 @ 9:34 AM
Study NCT ID:
NCT00499889
Status:
TERMINATED
Last Update Posted:
2012-04-23
First Post:
2007-07-10
Brief Title:
Imatinib Mesylate Busulfan Fludarabine and Antithymocyte Globulin for CML Patients
Sponsor:
MD Anderson Cancer Center
Organization:
MD Anderson Cancer Center
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Leukemia |